Skip to content

Type: Press Releases

Friends of Cancer Research Statement on the VALID Act of 2022

New Research Shows Breakthrough Therapy Designated Drugs Provide Maximum Benefit to Patients

Friends of Cancer Research Statement on the Proposed House and Senate FDA User Fee Legislation

Dr. Ned Sharpless Stepping Down as National Cancer Institute Director

Statement from Friends of Cancer Research on Dr. Robert Califf’s Confirmation as FDA Commissioner

Statement from Friends of Cancer Research on President & Dr. Biden’s Cancer Moonshot

New HRD Publication Sets the Stage for Unique Collaboration

Washington, DC – January 27, 2022 – Friends of Cancer Research (Friends) is excited to announce its latest publication “Homologous Recombination Deficiency: Concepts, Definitions, and Assays.” Findings from this manuscript set the foundation for the ongoing Homologous Recombination Deficiency (HRD) Harmonization Project, a unique research partnership focused on developing strategies to assess assay performance and…

Dr. Robert Califf Letter of Support 2021

President Biden to Nominate Dr. Robert Califf as FDA Commissioner

Washington, DC – November 12, 2021 – Friends of Cancer Research (Friends) strongly supports the nomination of Dr. Robert Califf to serve as the next Commissioner of the U.S. Food and Drug Administration (FDA) and urges the 117th Congress to work quickly to confirm his appointment. Friends also applauds the incredible leadership of Dr. Janet Woodcock who,…

Friends of Cancer Research Announces Results from Phase 2 of Tumor Mutational Burden Harmonization Project